Skip to main content
Topics

Biotechnology

Biotechnology drives breakthroughs in medicine, agriculture, and manufacturing. The National Academies assess advances, risks, and regulations that shape responsible innovation in the life sciences. 

What's happening

Protecting Human Health through Biotechnology Breakthroughs and Platforms

Perspectives

On November 15, 2020, after 4 months in large-scale Phase 3 clinical testing, Moderna received resounding proof that its new class of medicines based on messenger RNA encased in lipid nanoparticles could be safely deployed as a highly effective vaccine to combat the COVID-19 pandemic.

May 25, 2021
Gloved hand worked with test samples

Featured work

Upcoming events

See all events

Units

International Forum on Responsible Bioeconomy Innovation

Roundtable/Forum

Forum on Synthetic Biology

Roundtable/Forum

Completed

Life Sciences and Biotechnology Program Area

Oversight Unit

In Progress
Magnified body's raw materials, stem cells

Office of Congressional and Government Affairs (OCGA)

Oversight Unit

In Progress

Biomedical and Health Sciences Program Area

Oversight Unit

In Progress

Center for Advancing Science and Technology (CAST)

Oversight Unit

In Progress

Health Care and Public Health Program Area

Oversight Unit

In Progress
Extensive series of patients, doctors and nurses of various ages and ethnicities in a modern exam room. Used for: A Long COVID Definition A Chronic, Systemic Disease State with Profound Consequences

Climate Crossroads

Oversight Unit

In Progress

Transformative Science and Technology for the Department of Defense: Standing Committee and Seminar Series

Standing Committee

In Progress

Board on Human-Systems Integration

Standing Committee

In Progress
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.